Wm. Kevin Kelly

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Howard I. Scher, Michael J. Morris, Walter M. Stadler et al. · Journal of Clinical Oncology · 2016 · 1.6K citations

Medicine, Oncology, Urology +17

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Wm. Kevin Kelly, Victoria M. Richon, Owen A. O’Connor et al. · PubMed · 2003 · 623 citations

Medicine, Oncology, Pharmacology +16

Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome

Wm. Kevin Kelly, Howard I. Scher · The Journal of Urology · 1993 · 352 citations

Medicine, Endocrinology, Urology +15

Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer

Eric J. Small, Mark W. Frohlich, Robert Bok et al. · Journal of Clinical Oncology · 2000 · 184 citations

Medicine, Pharmacology, Pharmacotherapy +15

MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer

Renée de Leeuw, Christopher McNair, Matthew J. Schiewer et al. · Clinical Cancer Research · 2018 · 126 citations

Medicine, Oncology, Pharmacology +17